Home » Topics » Conferences

Conferences
RSS

GW-273227, a sodium channel blocker for the treatment of pain

Sep. 17, 1998

First group 1 mGluR antagonist with submicromolar potency described by Lilly

Sep. 17, 1998

Organon discovers new pharmacophore providing potent, orally active thrombin inhibitors

Sep. 17, 1998

Glaxo Wellcome studies lamotrigine analogues in the search for new anticonvulsants

Sep. 17, 1998

Russian scientists identify GABA analogue with hypotensive activity

Sep. 17, 1998

Astra Arcus develops first full, selective alpha7 nAChR agonist

Sep. 17, 1998

Selective 5-HT2C antagonist selected for development at Organon

Sep. 17, 1998

Japanese and Dutch scientists design LTD4 and dual LTD4/H1 antagonists

Sep. 17, 1998

Merck KGaA discovers potent dual 5-HT1A antagonist and 5-HT reuptake inhibitor

Sep. 16, 1998

SKB selects V-ATPase inhibitor SB-242784 for further evaluation

Sep. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...